Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for eosinophilic gastrointestinal disease has been reported in the published literature.
3 clinical trials registered, 1 recruiting. Interventions under study include other interventions and drug therapy. Pipeline includes 1 PHASE2. Research is sponsored by a mix of industry and academic institutions.
71 publications have been identified in PubMed for eosinophilic gastrointestinal disease. Research spans Case Report / Case Series (30%), Review / Meta-Analysis (24%), and Epidemiology / Natural History (21%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 21 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 4:33 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 17 | 24% |
Disease patterns and progression | 15 | 21% |
Laboratory research | 7 | 10% |
Testing and diagnosis research | 5 | 7% |
New treatment approaches | 4 | 6% |
Other research | 1 | 1% |
Clinical study results | 1 | 1% |
Aleman S (2026). [PMID: 41843038](https://pubmed.ncbi.nlm.nih.gov/41843038/). *Dig Dis Sci*. [Epidemiology / Natural History]
Qadri HA (2026). [PMID: 41716921](https://pubmed.ncbi.nlm.nih.gov/41716921/). *Oxford medical case reports*. [Case Report / Case Series]
Kapalu CL (2026). [PMID: 41521613](https://pubmed.ncbi.nlm.nih.gov/41521613/). *Journal of pediatric gastroenterology and nutrition*. [Case Report / Case Series]
Chitapanarux T (2026). [PMID: 41667204](https://pubmed.ncbi.nlm.nih.gov/41667204/). *BMJ case reports*. [Diagnostic / Biomarker]
Ketchem CJ (2026). [PMID: 40914297](https://pubmed.ncbi.nlm.nih.gov/40914297/). *The Journal of allergy and clinical immunology*. [Epidemiology / Natural History]
Granot M (2026). [PMID: 42058471](https://pubmed.ncbi.nlm.nih.gov/42058471/). *Front Pediatr*. [Diagnostic / Biomarker]
Miyaguchi K (2026). [PMID: 41019197](https://pubmed.ncbi.nlm.nih.gov/41019197/). *DEN open*. [Epidemiology / Natural History]
Qasim A (2026). [PMID: 42083679](https://pubmed.ncbi.nlm.nih.gov/42083679/). *Cureus*. [Case Report / Case Series]
Trimarchi MP (2026). [PMID: 41865802](https://pubmed.ncbi.nlm.nih.gov/41865802/). *J Allergy Clin Immunol*. [Basic Science / Preclinical]
Sasai M (2026). [PMID: 41840871](https://pubmed.ncbi.nlm.nih.gov/41840871/). *Pediatr Int*. [Case Report / Case Series]
AI-curated news mentioning eosinophilic gastrointestinal disease
Updated Aug 3, 2026
A recent study published in PubMed explores multifocal giant granular cell tumors of the alimentary canal alongside eosinophilic gastrointestinal disease. This research may provide insights into the pathophysiology and potential treatment avenues for these rare conditions.
A recent study published in PubMed highlights the prevalence and economic burden of non-esophageal eosinophilic gastrointestinal diseases in the United States. This research provides valuable insights into the healthcare costs associated with these conditions, which may inform future treatment and policy decisions.